TSTL - Ticker AI Digest

Tristel 📰 2
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (TSTL) 2
TSTL 10:57
Tristel
Exercise of Share Options and Total Voting Rights
TSTL 06:01
Tristel
Notice of Results
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Tristel plc, a global infection prevention company listed on the London Stock Exchanges AIM market (AIM: TSTL), has announced the release date for its interim results for the six-month period ending December 31, 2025. The results will be published on **Monday, March 2, 2026**.
Key events surrounding the announcement include
1. **Analyst Briefing**A London-based briefing for analysts will take place on March 2, 2026, at 11:00 AM. Registration details are available via Walbrook PR.
2. **Investor Presentations**Two presentations will be held on the same day
An online presentation via the Investor Meet Company platform at 9:30 AM, open to all existing and potential shareholders.
An in-person presentation in the City of London at 4:30 PM, followed by refreshments. Both events will feature CEO Matt Sassone and CFO Anna Wasyl.
Tristel, headquartered near Cambridge, specializes in infection prevention products using proprietary chlorine dioxide (ClO2) chemistry. The company operates globally, targeting double-digit revenue growth, a 25%+ EBITDA margin, and progressive dividend growth.
For further details, investors can contact Walbrook PR or visit Tristel’s investor website. The results presentation will also be available on the company’s website on the day of the announcement.
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
TSTL 06:01
Tristel
Notice of Results
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Tristel plc, a global infection prevention company listed on the London Stock Exchanges AIM market (AIM: TSTL), has announced the release date for its interim results for the six-month period ending December 31, 2025. The results will be published on **Monday, March 2, 2026**.
Key events surrounding the announcement include
1. **Analyst Briefing**A London-based briefing for analysts will take place on March 2, 2026, at 11:00 AM. Registration details are available via Walbrook PR.
2. **Investor Presentations**Two presentations will be held on the same day
An online presentation via the Investor Meet Company platform at 9:30 AM, open to all existing and potential shareholders.
An in-person presentation in the City of London at 4:30 PM, followed by refreshments. Both events will feature CEO Matt Sassone and CFO Anna Wasyl.
Tristel, headquartered near Cambridge, specializes in infection prevention products using proprietary chlorine dioxide (ClO2) chemistry. The company operates globally, targeting double-digit revenue growth, a 25%+ EBITDA margin, and progressive dividend growth.
For further details, investors can contact Walbrook PR or visit Tristel’s investor website. The results presentation will also be available on the company’s website on the day of the announcement.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 1
TSTL 06:01
Tristel
Positive H1 Trading Update & Directorate Change
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Tristel PLC, a manufacturer of infection prevention products, released a positive trading update for the first half (H1) of its fiscal year ending December 31, 2025. The company reported strong financial performance, including a 14% year-on-year revenue increase, maintained gross margins of 81%, and a 17% rise in adjusted EBITDA, with margins at 28%. Tristel remains debt-free, cash generative, and ended H1 with cash balances of £13.3m. The company is on track to meet full-year market expectations and internal targets, with continued growth in the U.S. market.
Additionally, Tristel announced a directorate change, with CEO Matt Sassone resigning to take a global leadership role at a large U.S. multinational. Sassone will remain in his position until the end of the financial year to ensure a smooth transition. The board has begun the search for a new CEO and expressed confidence in the existing management team to maintain business momentum. Both Sassone and Board Chair Bruno Holthof emphasized the company’s strong position, robust growth strategy, and compelling investment case. Tristel will announce its interim results in early March 2026.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 4
TSTL 10:57
Tristel
Exercise of Share Options and Total Voting Rights
TSTL 06:01
Tristel
Notice of Results
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Tristel plc, a global infection prevention company listed on the London Stock Exchanges AIM market (AIM: TSTL), has announced the release date for its interim results for the six-month period ending December 31, 2025. The results will be published on **Monday, March 2, 2026**.
Key events surrounding the announcement include
1. **Analyst Briefing**A London-based briefing for analysts will take place on March 2, 2026, at 11:00 AM. Registration details are available via Walbrook PR.
2. **Investor Presentations**Two presentations will be held on the same day
An online presentation via the Investor Meet Company platform at 9:30 AM, open to all existing and potential shareholders.
An in-person presentation in the City of London at 4:30 PM, followed by refreshments. Both events will feature CEO Matt Sassone and CFO Anna Wasyl.
Tristel, headquartered near Cambridge, specializes in infection prevention products using proprietary chlorine dioxide (ClO2) chemistry. The company operates globally, targeting double-digit revenue growth, a 25%+ EBITDA margin, and progressive dividend growth.
For further details, investors can contact Walbrook PR or visit Tristel’s investor website. The results presentation will also be available on the company’s website on the day of the announcement.
TSTL 06:01
Tristel
Positive H1 Trading Update & Directorate Change
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Tristel PLC, a manufacturer of infection prevention products, released a positive trading update for the first half (H1) of its fiscal year ending December 31, 2025. The company reported strong financial performance, including a 14% year-on-year revenue increase, maintained gross margins of 81%, and a 17% rise in adjusted EBITDA, with margins at 28%. Tristel remains debt-free, cash generative, and ended H1 with cash balances of £13.3m. The company is on track to meet full-year market expectations and internal targets, with continued growth in the U.S. market.
Additionally, Tristel announced a directorate change, with CEO Matt Sassone resigning to take a global leadership role at a large U.S. multinational. Sassone will remain in his position until the end of the financial year to ensure a smooth transition. The board has begun the search for a new CEO and expressed confidence in the existing management team to maintain business momentum. Both Sassone and Board Chair Bruno Holthof emphasized the company’s strong position, robust growth strategy, and compelling investment case. Tristel will announce its interim results in early March 2026.
TSTL 14:11
Tristel
Exercise of Share Options and Total Voting Rights

AI Crunch

Single-Ticker AI Crunch
TSTL signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Tristel. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full TSTL AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for TSTL on 2026-02-06.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
177346704
Enterprise Value
152780376
Public Float
96.11
Broker Target
473.333
Shares Out
47931543
Long Interest
80
Short Interest
20
Exchange
LSE
Currency Code
GBX
ISIN
GB00B07RVT99
Market
LSE - AIM
Sector
Health Care Providers
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
0.14
Ex Divi
2026-03-19
Earnings Date
2026-02-23
Net Debt
-2767000.0
Cash
8644000.0
EPS
0.16
Net Income
6640000.0
Revenue
46462000.0
Enterprise Value
152780376
Trailing PE
23.125
Forward PE
19.6078
Price Sales TTM
3.5801
Price Book MRQ
5.4287
EV Revenue
3.5261
EV EBITDA
13.5512

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
26.9427
Institutions As Of
2025-11-12
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
3
Sale Director Dealing
3
Purchase TR1
1
Sale TR1
6
Broker Coverage Rows
2
Institution Holders Tracked
5
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

2 live catalysts just hit TSTL.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2026-02-06 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
2 Today
Catalyst Pulse
Tristel has fresh news flow feeding the chart narrative.
10:57 Today's Catalyst Exercise of Share Options and Total Voting Rights
AI Charts Studio
TSTL Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-02-06 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast -3.37%
RSI Gauge
Price Change
AI Forecast